20 Oct 2026
The AI-PMP study has successfully completed recruitment, marking an important milestone for AI-PROGNOSIS
The AI-PROGNOSIS project has reached an important milestone with the successful completion of recruitment for the AI-based Progression and Medication Response Prediction (AI-PMP) study.
A total of 103 participants were recruited, exceeding the initial target of 100.
The AI-PMP study is a multicentre, proof-of-concept study designed to validate AI models predicting Parkinson’s disease progression and medication response. It also aims to provide preliminary evidence of their clinical utility and evaluate the usability of the mAI-Care and mAI-Insights applications among people with Parkinson’s disease and healthcare professionals.
This achievement reflects the strong collaborative effort of the clinical and technical partners involved in the study and marks an important step forward for AI-PROGNOSIS.
With recruitment now complete, the focus moves to analysing the data collected during the study and translating participants’ valuable contributions into meaningful scientific results.
Learn more about AI-PROGNOSIS clinical studies:
